The Role of Nitric Oxide in NeurodegenerationPotential for Pharmacological Intervention

被引:0
|
作者
José Antonio Molina
Félix Javier Jiménez-Jiménez
Miguel Ortí-Pareja
José Antonio Navarro
机构
[1] Hospital Universitario Doce de Octubre,Department of Neurology
[2] Hospital ‘Príncipe de Asturias’,Department of Neurology
[3] Hospital Universitario Doce de Octubre,Department of Biochemistry
来源
Drugs & Aging | 1998年 / 12卷
关键词
Nitric Oxide; Amyotrophic Lateral Sclerosis; Adis International Limited; MPTP; Nitric Oxide Synthetase;
D O I
暂无
中图分类号
学科分类号
摘要
Nitric oxide (NO) is involved in important physiological functions of the CNS, including neurotransmission, memory and synaptic plasticity. Depending on the redox state of NO, it can act as a neurotoxin or it can have a neuroprotective action. Data suggest that NO may have a role in the pathogenesis of neurodegenerative disorders such as Parkinson’s disease, Alzheimer’s disease and Huntington’s disease. Additionally, these data indicate that inhibitors of the NO-synthesising enzyme, NO synthase, may be useful as neuroprotective agents in these diseases. In animal models, NOS inhibitors have been shown to prevent the neurotoxicity induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and other dopaminergic toxins. However, the clinical effects of NOS inhibitors remain unknown.
引用
收藏
页码:251 / 259
页数:8
相关论文
共 50 条
  • [1] The role of nitric oxide in neurodegeneration - Potential for pharmacological intervention
    Molina, JA
    Jimenez-Jimenez, FJ
    Orti-Pareja, M
    Navarro, JA
    DRUGS & AGING, 1998, 12 (04) : 251 - 259
  • [2] The role of nitric oxide in heart failure - Potential for pharmacological intervention
    Macdonald, P
    Schyvens, C
    Winlaw, D
    DRUGS & AGING, 1996, 8 (06) : 452 - 458
  • [3] The physiological role and pharmacological potential of nitric oxide in neutrophil activation
    Armstrong, R
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (08) : 1501 - 1512
  • [4] Nitric oxide generation from pharmacological nitric oxide donors
    Kishnani, NS
    Fung, HL
    NITRIC OXIDE, PT A - SOURCES AND DETECTION OF NO; NO SYNTHASE, 1996, 268 : 259 - 265
  • [5] RETRACTED: Pharmacological preconditioning with resveratrol: role of nitric oxide (Retracted Article)
    Hattori, R
    Otani, H
    Maulik, N
    Das, DK
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 282 (06): : H1988 - H1995
  • [6] Role of inducible nitric oxide synthase in pharmacological ''preconditioning'' with monophosphoryl lipid A
    Zhao, L
    Weber, PA
    Smith, JR
    Comerford, ML
    Elliott, GT
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (06) : 1567 - 1576
  • [7] A pharmacological study on the role of nitric oxide in the pathogenesis of experimental allergic encephalomyelitis
    Scott, GS
    Williams, KI
    Bolton, C
    INFLAMMATION RESEARCH, 1996, 45 (10) : 524 - 529
  • [8] Regulation of nitric oxide synthase activity and pharmacological properties of nitric oxide
    Morin, FC
    PEDIATRIC NEPHROLOGY, 1998, 12 (06) : 504 - 505
  • [9] Role of inducible nitric oxide synthase (iNOS) in pharmacological ''preconditioning'' with monophosphoryl lipid A
    Zhao, L
    Weber, PA
    Comerford, ML
    Smith, JR
    Kehl, J
    Elliott, GT
    CIRCULATION, 1996, 94 (08) : 2459 - 2459
  • [10] Pivotal role of nitric oxide in delayed pharmacological preconditioning against myocardial infarction
    Xi, L
    Kukreja, RC
    TOXICOLOGY, 2000, 155 (1-3) : 37 - 44